Biotech

All Articles

Sanofi fails MS research study, inflicting another strike to Denali contract

.Sanofi has actually quit a phase 2 hardship of Denali Therapeutics-partnered oditrasertib in numero...

Turnstone gives up 60%, shocks C-suite to stretch out money

.Turnstone Biologics is decreasing its head count through 60% and also shaking up its C-suite to kee...

Gilead quits on $15M MASH wager after mulling preclinical data

.In a year that has actually seen a confirmation and also a range of readouts for metabolic dysfunct...

Texas biotech centers cancer treaty, pins hopes on being overweight

.Alaunos Therapeutics is actually axing an arrangement along with Precigen, giving up licensing civi...

Capricor portions even more information for DMD treatment after triggering BLA

.Capricor Rehabs is actually taking a victory tour for their period 2 Duchenne muscle dystrophy (DMD...

FDA areas Kezar lupus test in hold adhering to 4 patient deaths

.The FDA has actually placed Kezar Life Sciences' lupus trial on grip after the biotech hailed four ...

Phase 3 Intellectual Rock trial strikes SMA objective, sending stock up 200%

.A phase 3 trial of Academic Stone's spine muscle atrophy (SMA) prospect has actually struck its mai...

CAMP 4 is actually newest to eye IPO, while Upstream spells out $182M program

.RNA biotech CAMP4 Therapies has actually marked out plans for a $67 thousand IPO, along with inflam...

Galecto gets leukemia medicine, falls bone tissue cancer cells possession in pivot

.A year after the failing of an idiopathic pulmonary fibrosis applicant sent Galecto on a look for s...

Judo tosses down $100M to knock out kidney disease

.Taking the mat is Judo Biography, an up-and-coming biotech equipped along with $one hundred thousan...